[HTML][HTML] Unmet medical needs in chronic, non-communicable inflammatory skin diseases
H Ujiie, D Rosmarin, MP Schön, S Ständer… - Frontiers in …, 2022 - frontiersin.org
An estimated 20–25% of the population is affected by chronic, non-communicable
inflammatory skin diseases. Chronic skin inflammation has many causes. Among the most …
inflammatory skin diseases. Chronic skin inflammation has many causes. Among the most …
[HTML][HTML] Autoimmunity against laminin 332
S Patzelt, E Schmidt - Frontiers in Immunology, 2023 - frontiersin.org
Laminin 332 is a heterotrimeric structural protein of the basal membrane zone (BMZ) of the
skin and adjacent mucosal tissues. The importance of laminin 332 for the structural integrity …
skin and adjacent mucosal tissues. The importance of laminin 332 for the structural integrity …
European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology …
E Schmidt, H Rashid, AV Marzano… - Journal of the …, 2021 - Wiley Online Library
This guideline has been initiated by the task force Autoimmune Blistering Diseases of the
European Academy of Dermatology and Venereology, including physicians from all relevant …
European Academy of Dermatology and Venereology, including physicians from all relevant …
Bullous autoimmune dermatoses–clinical features, diagnostic evaluation, and treatment options.
NV Beek, D Zillikens, E Schmidt - Deutsches Arzteblatt international, 2021 - europepmc.org
Background Bullous autoimmune dermatoses are a clinically and immunopatho-logically
heterogeneous group of diseases, characterized clinically by blisters or erosions of the skin …
heterogeneous group of diseases, characterized clinically by blisters or erosions of the skin …
Autoimmune bullous dermatoses
MM Holtsche, K Boch, E Schmidt - JDDG: Journal der …, 2023 - Wiley Online Library
Autoimmune bullous dermatoses (AIBD) are a heterogeneous group of about a dozen
diseases characterized clinically by erosions and blisters and immunopathologically by …
diseases characterized clinically by erosions and blisters and immunopathologically by …
Pemphigus‐und Pemphigoid‐Erkrankungen: Klinik, Diagnostik und Therapie: Pemphigus and pemphigoids: Clinical presentation, diagnosis and therapy
D Didona, MF Schmidt, R Maglie… - JDDG: Journal der …, 2023 - Wiley Online Library
Pemphigus und Pemphigoid sind seltene Autoimmunkrankheiten der Haut mit potenziell
lebensbedrohlichem Verlauf. Autoantikörper gegen epidermale und junktionale …
lebensbedrohlichem Verlauf. Autoantikörper gegen epidermale und junktionale …
[HTML][HTML] Gut dysbiosis in ocular mucous membrane pemphigoid
L Low, K Suleiman, M Shamdas… - Frontiers in cellular …, 2022 - frontiersin.org
Mucous Membrane Pemphigoid is an orphan multi-system autoimmune scarring disease
involving mucosal sites, including the ocular surface (OcMMP) and gut. Loss of tolerance to …
involving mucosal sites, including the ocular surface (OcMMP) and gut. Loss of tolerance to …
[HTML][HTML] Anti-Idiotypic mRNA Vaccine to Treat Autoimmune Disorders
SK Niazi - Vaccines, 2023 - mdpi.com
The 80+ existing autoimmune disorders (ADs) affect billions with little prevention or
treatment options, except for temporary symptomatic management, leading to enormous …
treatment options, except for temporary symptomatic management, leading to enormous …
[HTML][HTML] Comparison of two diagnostic assays for anti-laminin 332 mucous membrane pemphigoid
S Goletz, F Giurdanella, MM Holtsche… - Frontiers in …, 2021 - frontiersin.org
Anti-laminin 332 mucous membrane pemphigoid (MMP) is an autoimmune blistering
disease characterized by predominant mucosal lesions and autoantibodies against laminin …
disease characterized by predominant mucosal lesions and autoantibodies against laminin …
Mucous membrane pemphigoid
G Du, S Patzelt, N van Beek, E Schmidt - Autoimmunity Reviews, 2022 - Elsevier
Mucous membrane pemphigoid (MMP) is a clinically and immunopathologically
heterogenous disease with an incidence of about 2/million inhabitants/year in central …
heterogenous disease with an incidence of about 2/million inhabitants/year in central …